重复远程缺血后适应对缺血性卒中患者梗死体积的影响(REPOST):随机临床试验研究方案
REPOST试验计划纳入200例缺血性卒中患者,住院期间随机接受每日两次远程缺血后适应或假处理,单盲安慰剂对照,主要结局为出院时MRI弥散加权成像测量的梗死体积,次要结局包括改良Rankin量表、美国国立卫生研究院卒中量表、生活质量及心脑血管发病率与死亡率,并采血检测炎症和血管健康生物标志物。
要点
- 重复远程缺血后适应指每日两次、每次4个循环5分钟袖带充气至收缩压以上>20 mmHg后放气5分钟。
- 主要结局为出院时MRI弥散加权成像测量的梗死体积,次要结局包括改良Rankin量表和美国国立卫生研究院卒中量表。
- 将采静脉血评估炎症和血管健康生物标志物,以探索远程缺血后适应的可能机制。
核心结论
- 本研究旨在评估缺血性卒中后重复远程缺血后适应能否减小梗死体积,并可能转化为临床结局的改善。
- 作者指出,既往动物和人类研究使用单次远程缺血适应报告了减轻神经损伤的潜在效应,但尚无研究探索卒中后住院期间重复应用远程缺血后适应的潜在生理和临床效应。
研究设计与样本
- 随机单盲安慰剂对照试验,计划纳入200例缺血性卒中患者,住院期间随机分配至每日远程缺血后适应组或假处理组。
- 干预为每日两次、每次4个循环5分钟袖带充气至收缩压以上>20 mmHg(远程缺血后适应)或50 mmHg(对照),随后放气5分钟。
主要发现
- 主要结局为出院时MRI弥散加权成像测量的梗死体积。
- 次要结局包括改良Rankin量表、美国国立卫生研究院卒中量表、生活质量以及心脑血管发病率与死亡率。
- 将采集静脉血评估炎症和血管健康生物标志物,以探索远程缺血后适应的可能机制。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Remote ischemic postconditioning (rIPostC) refers to the observation that repeated, short periods of ischemia protect remote areas against tissue damage during and after prolonged ischemia. Based on previous observations of a potential neuroprotective effect of rIPostC, the aim of this study is to evaluate whether repeated rIPostC after an ischemic stroke can reduce infarct size, which could be translated to an improvement in clinical outcomes. METHODS/DESIGN: We will enroll 200 ischemic stroke patients to daily rIPostC or sham conditioning during hospitalization into a randomized single-blind placebo-controlled trial. The intervention consists of twice daily exposure to four cycles of 5-min cuff inflation around the upper arm to > 20 mmHg above systolic blood pressure (i.e., rIPostC) or 50 mmHg (i.e., control), followed by 5 minutes of deflation. The primary outcome is infarct size, measured using an MRI diffusion-weighted image at the end of hospitalization. Secondary outcomes include the Modified Rankin Scale, National Institutes of Health Stroke Scale, quality of life, and cardiovascular and cerebrovascular morbidity and mortality. To explore possible underlying mechanisms of rIPostC, venous blood will be sampled to assess biomarkers of inflammation and vascular health. DISCUSSION: Previous studies in animals and humans, using a single bout of remote ischemic conditioning, report a potential effect of rIPostC in attenuating neural damage. Although repeated rIPostC has been investigated for cardiovascular disease patients and preclinical stroke models, no previous study has explored the potential physiological and clinical effects of repeatedly applying rIPostC during the hospitalization phase after a stroke. TRIAL REGISTRATION: Netherlands Trial Register, NTR6880 . Registered on 8 December 2017.
引用
- Landman T, Schoon Y, Warlé M, et al. The effect of repeated remote ischemic postconditioning on infarct size in patients with an ischemic stroke (REPOST): study protocol for a randomized clinical trial. Trials. 2019. PMID: 30876432. doi:10.1186/s13063-019-3264-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。